Entering the field of psychedelic therapy, whether as a therapist or a client, means learning about an ever-growing, sometimes bewildering array of psychedelic substances. My friends in the field have ...

Small Pharma is evaluating the best way to administer N,N-dimethyltryptamine (DMT) in a therapeutic setting for the treatment of depressive disorders. DMT—the primary psychoactive compound in ...

One of the most powerful psychedelics known, N,N-dimethyltryptamine (DMT) has been described as causing imaginative visuals akin to the dream state. It is typically consumed on its own or in ayahuasca ...

Benjamin holds a Master's degree in anthropology from University College London and has previously worked in the fields of psychedelic neuroscience and mental health. Benjamin holds a Master's degree ...

A $1.5 million gift to UC San Diego will help fund a research program into the biological and psychological effect of a powerful psychedelic in humans, it was announced Tuesday. N, ...

A Canadian-based pharmaceutical company has received approval to conduct a clinical study of the psychedelic compound DMT as a treatment for stroke. Under the plan, pharmaceutical development company ...

The burgeoning psychedelic therapeutics market experienced a boost Jan. 25 as Small Pharma Inc. announced its synthetic, intravenous formulation of N,N-dimethyltryptamine (DMT), SPL-026, led to a ...

Weed has been legal in Arizona since 2020, and with the state backing studies into psilocybin mushrooms, shrooms may be on their way. But a new study suggests Americans are on to something else.

Algernon Pharmaceuticals Inc. AGNPF has set up a clinical research program for the treatment of strokes, focused on its proprietary DMT analogue, AP-188. The company is also planning to begin a Phase ...

Known as the “spirit molecule” to psychedelics enthusiasts, N,N-Dimethyltryptamine (DMT) is said to produce vivid and strangely similar hallucinations for many who take it. Now, a new extended-state ...